Article

Probing the binding nature and stability of highly transmissible mutated variant Alpha to Omicron of SARS-CoV-2 RBD with ACE2 via molecular dynamics simulation

2022-11-15

Abstract excerpt

As of now there is no approved drug available as a causative agent of COVID-19. To resolve this issue, quickly identify a repurposed drug and develop new vaccines are the most promising solutions as it is the time-consuming process to design a new drug. As a therapeutic development, some vaccines and some repurposed drugs were approved to prevent people from SARS-CoV-2 infections during this pandemic period; all t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 76713568-594f-5f7e-8f8a-1456215370f1
DOI: 10.21203/rs.3.rs-2213388/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Probing the binding nature and stability of highly transmissible mutated variant Alpha to Omicron of SARS-CoV-2 RBD with ACE2 via molecular dynamics simulationDOI 10.21203/rs.3.rs-2213388/v1Read

Probing the binding nature and stability of highly transmissible mutated variant alpha to omicron of SARS-CoV-2 RBD with ACE2 via molecular dynamics simulation.Semantic proximity Read

Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor.Semantic proximity Read

Origin of the tight binding mode to ACE2 triggered by multi-point mutations in the omicron variant: a dynamic insight.Semantic proximity Read

Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein.Semantic proximity Read

Revealing the Molecular Interactions between Human ACE2 and the Receptor Binding Domain of the SARS-CoV-2 Wild-Type, Alpha and Delta Variants.Semantic proximity Read

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptorSemantic proximity Read

Computational analysis of affinity dynamics between the variants of SARS- CoV-2 spike protein (RBD) and human ACE-2 receptorSemantic proximity Read

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.Semantic proximity Read

Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.Semantic proximity Read

Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants.Semantic proximity Read

SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibilitySemantic proximity Read

A computational approach to evaluate the combined effect of SARS-CoV-2 RBD mutations and ACE2 receptor genetic variants on infectivity: The COVID-19 host-pathogen nexusSemantic proximity Read